Fingolimod

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Major congenital malformations0.85 [0.06, 12.12]30%2 studies674not evaluable NA
All congenital malformations (majors, minors, majors and minors, or unspecified)0.12 [0.00, 7.22]-1 study332not evaluable NA

Growth parameters and prematurity
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Preterm (< 37 weeks)1.32 [0.47, 3.69]0%2 studies19250not evaluable NA

Intrauterine deaths
Adverse outcome VerdictOR 95%CII2k No. casesNo. exposedpublication biasROB???
Elective termination of pregnancy0.88 [0.16, 4.97]75%3 studies82136not evaluable NA
Early intrauterine death (< 22 weeks)0.77 [0.30, 2.00]0%2 studies28124not evaluable NA
Intrauterine deaths (as a whole)1.30 [0.16, 10.24]-1 study5112not evaluable NA
Therapeutic terminations of pregnancy0.98 [0.06, 16.09]-1 study263not evaluable NA

Hide endpoints reported in only one study ...